Jun 29, 2022 | Uncategorized
JUNE 29, 2022 CAMBRIDGE, MA. Bolden Therapeutics, Inc., a biotechnology company developing first-in-class therapeutics to promote neurogenesis for the potential treatment of CNS illnesses, today announced being awarded a Small Business Innovative Research (SBIR) grant...
Jun 28, 2022 | Uncategorized
RI Bio, in collaboration with Providence Business News and RI Bio member AMGEN, has created a unique series of articles addressing key topics of concern designed to advance the life sciences. Executive Director Carol Malysz moderated a series of roundtables with Amgen...
Jan 20, 2022 | Uncategorized
Smithfield, RI – High Purity New England, a supplier of solutions and equipment for the biopharmaceutical industry, announced that they have received a $15M USD contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the office...
Jan 4, 2022 | Uncategorized
The National Institute on Aging (NIA) offers early-stage funding opportunities to small businesses and researchers looking to commercialize innovative treatments or technologies to help people enjoy healthier lives as they age. The NIA Small Business...
Dec 22, 2021 | Uncategorized
For Immediate Release:December 22, 2021 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of...